Seasonal influenza vaccine uptake in Germany 2007/2008 and 2008/2009: Results from a national health update survey

In 2008/2009 a nationwide cross-sectional telephone survey was conducted to assess, among other health-relevant parameters, seasonal influenza vaccination coverage. Data from 21,262 household-interviews representative of the adult population in Germany were collected and analyzed. In seasons 2007/20...

Full description

Saved in:
Bibliographic Details
Published in:Vaccine Vol. 29; no. 27; pp. 4492 - 4498
Main Authors: Böhmer, Merle M., Walter, Dietmar, Müters, Stephan, Krause, Gérard, Wichmann, Ole
Format: Journal Article
Language:English
Published: Kidlington Elsevier Ltd 15.06.2011
Elsevier
Elsevier Limited
Subjects:
ISSN:0264-410X, 1873-2518, 1873-2518
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In 2008/2009 a nationwide cross-sectional telephone survey was conducted to assess, among other health-relevant parameters, seasonal influenza vaccination coverage. Data from 21,262 household-interviews representative of the adult population in Germany were collected and analyzed. In seasons 2007/2008 and 2008/2009, vaccine uptake in individuals aged ≥60 years was 57% and 55% and in individuals with underlying chronic diseases 44% and 42%. Living in the eastern part of Germany, higher age, and medium household income level were independently associated with higher vaccine uptake in both target groups. Healthcare workers were significantly less frequently (21.9% in 2007/2008; 20.4% in 2008/2009) vaccinated than the general population (30.8% and 28.1%). Special effort must be undertaken to develop immunization strategies for improved vaccine uptake in target groups, especially in healthcare workers.
Bibliography:http://dx.doi.org/10.1016/j.vaccine.2011.04.039
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
ISSN:0264-410X
1873-2518
1873-2518
DOI:10.1016/j.vaccine.2011.04.039